These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 22277036)

  • 21. [Determination of serum argininosuccinate lyase in diagnosing liver diseases].
    Feng JF; Chen TM; Tu ZG
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):521-4. PubMed ID: 17669242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.
    Yilmaz Y; Ulukaya E; Dolar E
    Hepatology; 2009 Feb; 49(2):697; author reply 697. PubMed ID: 19035337
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum M30 levels are associated with survival in advanced gastric carcinoma patients.
    Yaman E; Coskun U; Sancak B; Buyukberber S; Ozturk B; Benekli M
    Int Immunopharmacol; 2010 Jul; 10(7):719-22. PubMed ID: 20362077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of M30, an apoptotic serum marker, in liver diseases.
    Altinbaş A; Çoban Ş; Başar Ö; Yüksel O
    Turk J Med Sci; 2015; 45(1):6-10. PubMed ID: 25790523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker.
    Olofsson MH; Cummings J; Fayad W; Brnjic S; Herrmann R; Berndtsson M; Hodgkinson C; Dean E; Odedra R; Wilkinson RW; Mundt KE; Busk M; Dive C; Linder S
    Cancer Biomark; 2009; 5(3):117-25. PubMed ID: 19407366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors.
    Tarle M; Kovacić K; Kastelan M
    Anticancer Res; 1993; 13(1):215-8. PubMed ID: 7682800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mismatch repair protein MSH2, cytokeratin 18 and cytokeratin 20 expression: clinicopathological correlation and prognostic value in colorectal cancer patients.
    González JJ; Bernardo CG; Sanz L; Fresno MF; Barbón E; Noval JG; Martínez E
    Hepatogastroenterology; 2007 Dec; 54(80):2266-71. PubMed ID: 18265645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CA 15-3, mucin-like carcinoma-associated antigen and tissue polypeptide-specific antigen: correlation to disease state and prognosis in breast cancer patients.
    Cohen AD; Gopas J; Karplus G; Cohen Y
    Isr J Med Sci; 1995; 31(2-3):155-9. PubMed ID: 7744585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma.
    Yao WJ; Chang CJ; Chan SH; Chow NH; Cheng HL; Tzai TS; Lin SN
    Anticancer Res; 1995; 15(6B):2819-23. PubMed ID: 8669871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a potentially useful serum biomarker.
    Barak V; Frenkel S; Valyi-Nagy K; Leach L; Apushkin MA; Lin AY; Kalickman I; Baumann NA; Pe'er J; Maniotis AJ; Folberg R
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4399-402. PubMed ID: 17898257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19.
    Gonzalez-Quintela A; García J; Campos J; Perez LF; Alende MR; Otero E; Abdulkader I; Tomé S
    Alcohol; 2006 Jan; 38(1):45-9. PubMed ID: 16762691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.
    Tsutsui M; Tanaka N; Kawakubo M; Sheena Y; Horiuchi A; Komatsu M; Nagaya T; Joshita S; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Aoyama T; Tanaka E; Sano K
    J Clin Gastroenterol; 2010 Jul; 44(6):440-7. PubMed ID: 20104187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De Ritis ratio as diagnostic marker of alcoholic liver disease.
    Majhi S; Baral N; Lamsal M; Mehta KD
    Nepal Med Coll J; 2006 Mar; 8(1):40-2. PubMed ID: 16827089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue polypeptide specific antigen (TPS) as a tumor marker in nasopharyngeal carcinoma.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(6C):4661-3. PubMed ID: 11205197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytokeratin tumor markers in ovarian carcinoma: tissue polypeptide specific antigen (TPS) and M3/M21].
    Hefler L; Tempfer C; Häusler G; Heinzl H; Kainz C
    Wien Klin Wochenschr; 1998 Oct; 110(18):635-41. PubMed ID: 9816636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of TPS and CA 15-3 assays for monitoring chemotherapy in metastatic breast cancer patients.
    Einarsson R; Lindman H; Bergh J
    Anticancer Res; 2000; 20(6D):5089-93. PubMed ID: 11326674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
    Yao WJ; Wang ST; Chow NH; Chang TT; Lin PW; Tu DG
    Cancer; 2002 Jul; 95(1):112-8. PubMed ID: 12115324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ α1-antitrypsin deficiency.
    Janciauskiene S; Wallmark A; Piitulainen E; Köhnlein T; Welte T; Sveger T
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):716-20. PubMed ID: 21617532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.